3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Conditions
Depression
6
Neoplasms
5
Anxiety Disorders
5
Melanoma
2
Depressive Disorder, Major
2
Pain
1
Osteosarcoma
1
Opioid-Related Disorders
1
Neoplasm Metastasis
1
Lymphoma
1
Hospice
1
Hematopoietic and Lymphatic System Neoplasm
1
Endocrine Gland Neoplasms
1
Depressive Disorder
1
Caregiver Distress
1
Carcinoma, Non-Small-Cell Lung
1
Agnosia
1
Interventions
Psychotherapy
1
Psilocybin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Hospice
×
Psilocybin
×
Clear all
NCT04950608
2026-02-17
PATH
Dana-Farber Cancer Institute
Phase 2
Completed
15 enrolled
26 charts